Pancreatic acinar cell carcinomas and mixed acinar-neuroendocrine carcinomas are more clinically aggressive than grade 1 pancreatic neuroendocrine tumours
Abstract
No abstract availableKeywords
Funding Information
- Asan Institute for Life Sciences (2015-554)
- National Research Foundation of Republic of Korea (NRF-2016R1A2B4009381)
- North American Neuroendocrine Tumour Society
- Neuroendocrine Tumour Research Foundation
This publication has 35 references indexed in Scilit:
- Nonductal Pancreatic CancersSurgical Pathology Clinics, 2016
- Cytological findings and BCL10 expression in pancreatic acinar cell carcinomaDiagnostic Cytopathology, 2016
- Acinar neoplasms of the pancreas—A summary of 25 years of researchSeminars in Diagnostic Pathology, 2016
- BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimensPathology International, 2013
- Cytomorphologic and immunophenotypical features of acinar cell neoplasms of the pancreasCancer Cytopathology, 2013
- Clinicopathologic Study of 62 Acinar Cell Carcinomas of the PancreasAmerican Journal of Surgical Pathology, 2012
- Pancreatic Acinar Cell Carcinoma: A Multi-institutional StudyJournal of Gastrointestinal Surgery, 2009
- An Algorithmic Approach to the Diagnosis of Pancreatic NeoplasmsArchives of Pathology & Laboratory Medicine, 2009
- Acinar Cell Carcinoma of the Pancreas in the United States: Prognostic Factors and Comparison to Ductal AdenocarcinomaJournal of Gastrointestinal Surgery, 2008
- 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinomaSurgery, 2008